Pertussis Market Overview: Trends, Treatments, and Opportunities

The Pertussis Market is poised for steady growth, fueled by rising awareness of the disease and ongoing advancements in interventions. Key players in this sector include Serum Institute of India, LG Chem, ILiAD Biotechnologies, Dynavax Technologies, Tianjin CanSino Biotechnology, Faron Pharmaceuticals, Kymab, BioNet, and others. With innovative vaccines entering the pipeline, the Pertussis Therapeutics Market is attracting significant attention from healthcare stakeholders globally.

Insights and Market Scope

DelveInsight’s report, “Pertussis Market Insights, Epidemiology, and Market Forecast – 2034”, provides a thorough analysis of the Pertussis Drugs Market. Covering historical and projected epidemiology, treatment patterns, emerging therapies, and market dynamics, the study spans key regions including the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan. The report focuses on trends between 2024 and 2034, offering detailed segmentation by therapy, drug class, and competitive landscape insights.

Understanding Pertussis and Its Diagnosis

Pertussis, commonly called whooping cough, is a severe respiratory infection caused by Bordetella pertussis. The disease progresses through three stages: catarrhal, paroxysmal, and convalescent. Accurate diagnosis remains challenging, requiring methods like culture, PCR, and serological testing, with paired sera tests recognized as the most reliable.

Prevention and Treatment Approaches

Vaccination remains the cornerstone of Pertussis Treatment Market strategies. In the U.S., DTaP and Tdap vaccines are widely administered, with recommendations for all adolescents and adults to receive at least three doses. Macrolide antibiotics, including erythromycin, clarithromycin, and azithromycin, are commonly used treatments, though side effects can impact patient adherence. Supportive care such as oxygen therapy, hydration, and avoiding respiratory irritants is essential for effective management.

Epidemiology and Market Size

In 2022, around 19 million individuals were vaccinated in the U.S., with 5 million adults receiving booster doses. Across the seven major markets (7MM), approximately 34 million people were vaccinated, a figure expected to rise as awareness, immunization guidelines, and vaccine development advance. The total Pertussis Treatment Market Size in the 7MM was valued at $3.5 billion in 2022, with the U.S. being the largest contributor.

Vaccine Landscape and Emerging Therapies

Notable vaccines driving the Pertussis Therapeutics Market include:

• ADACEL (Sanofi Pasteur): A trivalent booster for pertussis, tetanus, and diphtheria, available in 55 countries.

• BOOSTRIX (GSK): Recommended for individuals aged 10 and above, including maternal immunization programs.

Emerging candidates include:

• BPZE1 (ILiAD Biotechnologies): An intranasal booster in Phase IIb with FDA Fast Track designation.

• BK1310/MT-2355 (Mitsubishi Tanabe Pharma): A 5-in-1 combination vaccine slated for launch in Japan in FY2023.

Market Outlook and Competitive Landscape

While childhood vaccination rates are high, adult booster compliance remains low, highlighting a critical growth opportunity. The U.S. and European markets are highly competitive, with vaccines like PEDIARIX, PENTACEL, and Vaxelis shaping market dynamics. Mitsubishi leads the Japanese market with TETRABIK.

The report also covers adoption rates of new and upcoming vaccines, patient uptake trends, sales performance, and pipeline developments, including collaborations, patent filings, and regulatory progress. Insights from key opinion leaders validate current and emerging treatments and help stakeholders navigate the Pertussis Companies landscape effectively.

With ongoing innovations and increasing immunization awareness, the Pertussis Market and Pertussis Drugs Market are positioned for substantial growth in the coming decade. Latest Reports Acute Pyelonephritis Market | Asperger Syndrome Market | Attention Deficit Hyperactivity Disorder Adhd Market | Cardiopulmonary Management Device Market | Childhood Atropine For Myopia Progression Market | Cholangiocarcinoma Market | Dyspepsia Market | Emphysema Market | Genital Herpes Market | Growth Hormone Deficiency Market | Guillain-barré Syndrome Market | Hairy Cell Leukemia Market | Intestinal Obstruction Market | Malignant Fibrous Histiocytoma Market | Menopause Market | Metabolic Acidosis Market | Multiple Myeloma Market | Neurostimulation Devices Market